Copley Scientific

Copley Scientific The company is also active in detergent testing.

Founded in 1946, Copley Scientific is recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of test systems for other pharmaceutical dosage forms.

New nasal products bring new testing challenges. Each one brings new questions, new considerations and new opportunities...
30/08/2026

New nasal products bring new testing challenges. Each one brings new questions, new considerations and new opportunities to learn.

New devices. New formulations. New approaches to development. And with that comes fresh thinking about how nasal products are tested, characterised and understood.

That changing landscape will be a big part of the conversation at the IPAC-RS 2026 Nasal Innovation Forum.

Our CEO, Jamie Clayton, will be in New Jersey on 16–17 September, sharing ideas around the latest developments in nasal drug delivery and the testing approaches needed to support them.

If you’re working in this space, get in touch at [email protected] to arrange a meeting with Jamie, or come and find him at the Forum to share ideas, talk through the challenges you’re seeing and explore where nasal testing could go next.

Getting to grips with inhalation testing means understanding more than how to operate the equipment. Knowing why methods...
28/08/2026

Getting to grips with inhalation testing means understanding more than how to operate the equipment. Knowing why methods are set up in a particular way - and how those decisions affect your results - is just as important.

On 7–8 October, we’re partnering with A&M STABTEST, to deliver a FREE, two-day technical workshop in Mainz, Germany, designed for scientists working in inhaler testing, whether you are new to the field or looking to strengthen your existing knowledge.

Through practical sessions and expert-led discussion, you’ll explore how testing approaches are applied in practice and have the opportunity to discuss your own analytical challenges with inhaler testing experts.

➡️Spaces are limited. Secure your place today: https://events.am-labor.de/mz/workshop/07-08.10.26

Routine friability testing involves more than the test itself, with weighing, test set-up, sample loading and unloading ...
26/08/2026

Routine friability testing involves more than the test itself, with weighing, test set-up, sample loading and unloading and result calculation all forming part of the day-to-day workflow.

Copley’s FRVi Series is designed around these practical requirements, helping analysts simplify routine tablet friability testing.

With features designed to support weighing, testing, drum emptying and % friability calculation, the FRVi Series helps support key stages of the testing process.

Take a closer look at some of the practical considerations involved and see how the FRVi Series could support your laboratory.

Request a demo to see the system in action: https://bit.ly/4iqjaxQ

Room-level air conditioning is not the same as controlling conditions at the test station.In our EnviroMate™ application...
24/08/2026

Room-level air conditioning is not the same as controlling conditions at the test station.

In our EnviroMate™ application note, temperature and relative humidity were monitored inside an EnviroMate unit and across an air-conditioned lab over several days.

The results show why it is worth looking beyond room-level control when investigating variability in inhaler testing.

For labs investigating unexpected DDU or APSD variability, the immediate test environment is one area that should not be overlooked.
See the data here: https://bit.ly/3UvwXt1

Manual actuation can introduce an avoidable source of variability into MDI testing, from shake technique and shake-to-fi...
20/08/2026

Manual actuation can introduce an avoidable source of variability into MDI testing, from shake technique and shake-to-fire timing to actuation profile, repeat firing and firing-to-waste.

And these differences don’t have to be large. Recent data show that a change of just one second can influence delivered dose, making it harder to separate product performance from handling variability.

Automating these repetitive, operator-dependent steps can help create more controlled, repeatable test conditions, while freeing skilled analysts to focus on higher-value work.

Consistency matters for wasted shots too: unrepresentative firing-to-waste can influence the doses that remain in the device and, ultimately, the measurements that follow.

Copley’s Vertus® III+ and DecaVertus® III provide practical ways to introduce automation into MDI testing. Vertus® III+ automates shake, fire and flow control for repeatable actuation, while DecaVertus® III automates high-capacity firing-to-waste; helping reduce manual workload and improve consistency without requiring you to automate the entire workflow at once.

So, how many of these 5 signs above do you recognise in your own workflow?

➡️Explore our inhaler testing automation solutions: https://bit.ly/3UsijTj

For further insight on where automation can add value, explore our latest resources:

➡️Discover why automating MDI firing-to-waste could make a difference to your workflow: https://bit.ly/3U8bupX

➡️Take a closer look at the data in our latest ONdrugDelivery article, Automating MDI Actuation: Precision Data with Less Effort: https://bit.ly/4xejzrQ

And if you’re not sure where automation could fit into your current testing set-up, speak to a member of our team at [email protected].

Same impactor. A different view of inhaler performance.Compendial APSD gives us the standardised conditions needed for r...
17/08/2026

Same impactor. A different view of inhaler performance.

Compendial APSD gives us the standardised conditions needed for robust, repeatable measurement. But, of course, patients don’t inhale at a constant flow rate through a pharmacopoeial induction port.

That’s where Realistic APSD (rAPSD) adds another layer.

Building on the established NGI workflow, rAPSD introduces more patient-representative test conditions using:
• an Alberta Idealised Throat
• a breathing simulator
• a mixing inlet

Together, these components help us look at inhaler performance across more representative throat geometries and inhalation profiles.

Why does that matter? Because it can help reveal differences between test and reference products that may not be apparent under standard compendial conditions.

Compendial APSD and rAPSD serve different purposes. But when they are used together, they can give us a more complete picture of inhaler performance.

Explore rAPSD and our wider IVIVC resources: https://bit.ly/3Sus6rs

🗓️Are any of these events already in your diary?The Copley team has a busy programme of industry events ahead, bringing ...
13/08/2026

🗓️Are any of these events already in your diary?

The Copley team has a busy programme of industry events ahead, bringing valuable opportunities to connect with those working across inhalation and nasal drug delivery.

We are looking forward to the discussions these events will generate, from evolving approaches to bioequivalence and analytical testing to the wider challenges shaping OINDP development.

➡️Explore our upcoming events and find out where you can meet the team here: https://bit.ly/4xux86k

To arrange a meeting or discuss your testing requirements in advance, email us at [email protected].

We look forward to seeing many of you there.

For many low-GWP pMDI reformulation development teams, the challenge is no longer understanding why low-GWP reformulatio...
11/08/2026

For many low-GWP pMDI reformulation development teams, the challenge is no longer understanding why low-GWP reformulation is needed.

It is generating robust, comparable data while adapting established test methods to new propellants.

Vertus® III+ and DecaVertus® III support automated shake, fire and flow control, helping laboratories standardise key workflow variables and reduce operator-dependent variability across DDU and APSD studies.

Integrated exhaust extraction ports help laboratories safely manage flammable propellants, addressing an important practical consideration when introducing new formulations into established workflows.

Planning or progressing low-GWP reformulation studies?

Contact us at [email protected] to discuss how Copley can help you establish controlled, repeatable testing workflows for the next generation of inhaled products.

Soft mist inhalers are a newer class of orally inhaled product, combining metered-dose delivery with a slow-moving aeros...
05/08/2026

Soft mist inhalers are a newer class of orally inhaled product, combining metered-dose delivery with a slow-moving aerosol mist.

In our latest blog, we explore the fundamentals of SMI testing, including Delivered Dose Uniformity, APSD measurement, droplet evaporation and bioequivalence considerations.

🖥️Read the blog here: https://bit.ly/4h8bJe9

There is no single standard method for inhaled dissolution testing. So, what should guide your approach?Our recent webin...
03/08/2026

There is no single standard method for inhaled dissolution testing. So, what should guide your approach?

Our recent webinar explores three practical considerations for developing or refining a method:
➡️Dose collection
➡️Apparatus selection
➡️Test parameters and method development

The session also introduces the Inhaled Dissolution Apparatus™ IDA, a purpose-built starting point for inhaled dissolution method development.

Missed the live webinar? Watch it on demand for practical guidance to support your approach: https://attendee.gotowebinar.com/recording/7105122660947236100

Address

Colwick Quays Business Park
Nottingham
NG42JY

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 6:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Telephone

+441159616229

Website

Alerts

Be the first to know and let us send you an email when Copley Scientific posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share